Hedge Fund Stocks Based on Machine Learning: Returns up to 6.43% in 3 Days
Package Name: Hedge Fund StocksRecommended Positions: Short
Forecast Length: 3 Days (6/11/21 - 6/15/21)
I Know First Average: 1.59%
Read The Full Forecast
Package Name: Hedge Fund StocksRecommended Positions: Short
Forecast Length: 3 Days (6/11/21 - 6/15/21)
I Know First Average: 1.59%
Top Biotech Stocks Based on Pattern Recognition: Returns up to 228.03% in 3 Months
Package Name: Biotech Stocks ForecastRecommended Positions: Long
Forecast Length: 3 Months (3/9/21 - 6/9/21)
I Know First Average: 25.8%
Read The Full Forecast
High Risk Stocks Based on Stock Market Algorithm: Returns up to 77.98% in 3 Months
Package Name: Aggressive Stocks ForecastRecommended Positions: Long
Forecast Length: 3 Months (3/9/21 - 6/9/21)
I Know First Average: 12.75%
Read The Full Forecast
Stocks to Buy Based on Deep Learning: Returns up to 44.23% in 14 Days
Package Name: Aggressive Stocks ForecastRecommended Positions: Long
Forecast Length: 14 Days (5/12/21 - 5/26/21)
I Know First Average: 10.3%
Read The Full Forecast
Trade Ideas Based on Algo Trading: Returns up to 19.75% in 3 Days
Package Name: Aggressive Stocks ForecastRecommended Positions: Short
Forecast Length: 3 Days (5/21/21 - 5/24/21)
I Know First Average: 2.84%
Read The Full Forecast
OCGN Stock Forecast: Covaxin’s FDA Status Marks the Future
This OCGN stock forecast article was written by Maria Grishaev, Analyst at I Know First.
Executive Summary
- Ocugen had a good year in 2020. The stock price went up by 239.52% despite the COVID-19 pandemic.
- A deal to commercialize Covaxin in the U.S. was signed with Bharat Biotech can have an impact on revenue if the FDA will give the vaccine an Emergency Use Authorization.
- Quantitative analysis results indicate bullish signals after stock price topped out the moving average line.
- OCGN deserves a one-year target price of $13, representing potential revenue growth.
Read The Full Premium Article
Subscribe to receive exclusive PREMIUM content HereBiotech Stocks Based on Deep Learning: Returns up to 26.75% in 7 Days
Package Name: Biotech Stocks Forecast
Recommended Positions: Short
Forecast Length: 7 Days (5/9/21 - 5/17/21)
I Know First Average: 5.05%
Read The Full Forecast
Geneva WealthTech Awards Winner
Fintech Technology for Investment Competition Winner
We Are UBS Regional Finalist
I Know First is a WealthTech100 Company
We Are A FinTech Awards Finalist
Start Algorithmic Trading Today!
Gold & Commodity Forecasts
Currency Forecasts
Subscribe To The I Know First Newsletter
